Aggressive and Autoaggressive Behavior, Impulse Control Disorder, and Conduct Disorder

作者: Claudia Mehler-Wex , Marcel Romanos , Andreas Warnke

DOI: 10.1007/978-3-7091-1501-5_9

关键词:

摘要: Aggressive behavior can occur alone or as an accompanying symptom consequence of various psychiatric disorders classified in the International Classification Diseases, 10th revision (ICD-10) and Diagnostic Statistical Manual Mental Disorders, 5th edition (DSM-5). Aggression be directed against oneself (self-injury, suicidal thoughts, acts) others. different kinds disruptive (e.g., oppositional defiant disorder, conduct antisocial personality disorder), emotional dysregulation borderline disturbance impulse control (attention deficit/hyperactivity ADHD), cognitive deficiency co-occurring with intellectual disabilities, pervasive developmental disorders, psychosis bipolar trauma stress post-traumatic adjustment disorders), aggressive may drug-induced. Thus each kind behavioral psychopharmacological treatment symptoms aggression depends on associated individual conditions aggression. Various subtypes will benefit differently from pharmacotherapy.

参考文章(90)
JORGE L. ARMENTEROS, JOHN E. LEWIS, MARISABEL DAVALOS, Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study. Journal of the American Academy of Child and Adolescent Psychiatry. ,vol. 46, pp. 558- 565 ,(2007) , 10.1097/CHI.0B013E3180323354
Lily Hechtman, Brian Greenfield, Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder Pediatric Drugs. ,vol. 5, pp. 787- 794 ,(2003) , 10.2165/00148581-200305120-00002
Elizabeth Pappadopulos, Alanna Chait, Matthew Perkins, Sophie Woolston, Daniel F. Connor, Peter S. Jensen, Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. Journal de l'Académie canadienne de psychiatrie de l'enfant et de l'adolescent. ,vol. 15, pp. 27- 39 ,(2006)
Lokaranjit Chalasani, Ravi Kant, KN Roy Chengappa, Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset schizophrenia. The Canadian Journal of Psychiatry. ,vol. 46, pp. 965- 968 ,(2001) , 10.1177/070674370104601010
Stefano Comai, Michael Tau, Gabriella Gobbi, The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 1 Neurobiology Journal of Clinical Psychopharmacology. ,vol. 32, pp. 83- 94 ,(2012) , 10.1097/JCP.0B013E31823F8770
Ravishankar Nagaraj, Pratibha Singhi, Prahbhjot Malhi, Risperidone in children with autism: randomized, placebo-controlled, double-blind study. Journal of Child Neurology. ,vol. 21, pp. 450- 455 ,(2006) , 10.1177/08830738060210060801
V C Karumanchi, S D Karumanchi, A Yates, M L German, M P Fankhauser, A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism The Journal of Clinical Psychiatry. ,vol. 53, pp. 77- 82 ,(1992)
Eric Hollander, Managing Aggressive Behavior in Patients With Obsessive-Compulsive Disorder and Borderline Personality Disorder The Journal of Clinical Psychiatry. ,vol. 60, pp. 38- 44 ,(1999)
Michael G. Aman, Carin Binder, Atilla Turgay, Risperidone Effects in the Presence/Absence of Psychostimulant Medicine in Children with ADHD, Other Disruptive Behavior Disorders, and Subaverage IQ Journal of Child and Adolescent Psychopharmacology. ,vol. 14, pp. 243- 254 ,(2004) , 10.1089/1044546041649020